Intellia Therapeutics (NTLA)
NASDAQ:NTLA

Intellia Therapeutics (NTLA) Stock Investors

2,757 Followers
Based on 748,140 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.3% of all portfolios hold NTLA
On average, investors allocate 3.10% of their portfolios to NTLA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 748,140 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NTLA

0.4%
Last 7
Days
7.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NTLA, out of 748,140 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NTLA Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.97%
$27.66
Opened
1.96%
$25.33
Opened
0.00%
$27.74
Increased
3.60%
$25.89
Increased
2.48%
$21.98
Increased
2.08%
$20.76
Increased
0.67%
$25.30
Increased
1.19%
$56.92
Increased
0.84%
$54.83
Increased
0.16%
$21.98
Based on the activity of 14,206 investors who made their portfolios public
The table shows changes in NTLA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NTLA Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.81%
-0.56%
-1.68%
32.41B
Consumer Cyclical
Block
4.23%
-0.78%
+0.07%
42.02B
Technology
ChargePoint Holdings
4.17%
-1.03%
-2.53%
833.60M
Consumer Cyclical
Trade Desk
4.67%
-0.81%
+0.46%
46.96B
Technology
Airbnb
4.47%
-1.14%
+2.18%
95.31B
Consumer Cyclical
Zscaler
3.81%
-0.87%
+1.65%
28.50B
Technology
Fortinet
3.36%
+0.12%
-1.13%
44.68B
Technology
Applied Materials
4.53%
+0.28%
+5.71%
174.09B
Technology
Bristol-Myers Squibb
3.23%
-0.69%
+1.52%
86.44B
Healthcare
Mercadolibre
5.26%
-0.52%
+1.97%
83.65B
Consumer Cyclical
Based on the activity of 748,140 active portfolios
Open your Smart Portfolio

NTLA Investor Analysis

NTLA investors under 35

Under 35

3.7%
Last 30 days
Holdings Change
12.8%
of NTLA holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
NTLA investors between 35–55

Between 35–55

3.4%
Last 30 days
Holdings Change
50.0%
of NTLA holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
NTLA investors over 55

Over 55

11.2%
Last 30 days
Holdings Change
37.2%
of NTLA holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of NTLA stock investors
See who invests in NTLA according to age group and performance.

FAQ

How many retail Investors hold NTLA?
0.3% of TipRanks' retail investors hold NTLA in their portfolios.
    What is NTLA Investor Sentiment?
    NTLA’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of NTLA in the last 7 days?
      ▼ 0.4% of TipRanks' retail investors changed their holding of NTLA in the last 7 days.
        What percentage of retail investors changed their holding of NTLA in the last 30 days?
        ▲ 7.2% of TipRanks' retail investors changed their holding of NTLA in the last 30 days.
          What is the average age of retail investors who hold NTLA?
          The average age of NTLA Holders is between 35–55.
            What other stocks have NTLA investors also bought?
            NTLA Investors also bought DKNG, SQ, CHPT, TTD, ABNB, ZS, FTNT, AMAT, BMY, MELI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CRLCharles River Labs
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis